Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Erlotinib
80%
Pharmacokinetic
66%
ABCG2
66%
Carbon 11
60%
Blood-Brain Barrier
51%
Meropenem
44%
Endometrium Cancer
44%
Resveratrol
44%
Diethylstilbestrol
43%
Polyphenol
37%
Microdialysis
33%
Prasterone
33%
Polypeptide
32%
Estrone Sulfate
32%
SLCO1B3
27%
Effusion
27%
Normal Human
26%
Sulfatase
24%
Genistein
22%
Actaea racemosa
22%
Endometrium Carcinoma
22%
Androgen
22%
Cefuroxime
22%
Vancomycin
22%
Daidzein
22%
Feces microflora
22%
Cancer Model
22%
Rifampicin
22%
Estrogen Receptor Positive Breast Cancer
22%
Ovary Cancer
22%
Temozolomide
22%
Estrogen Receptor Alpha
21%
Carboplatin
17%
Antibiotics
16%
Cyanidin
14%
Galactoside
14%
Sulfate
14%
Androstenedione
13%
Dietary Supplement
11%
Estrone
10%
Cancer Growth
9%
Tariquidar
9%
Subarachnoid Hemorrhage
9%
Cell Culture
8%
Interleukin 6
8%
Volume of Distribution
7%
Ciclosporin
7%
Estradiol 17 Glucuronide
7%
Intestine Enzyme
7%
Immunology and Microbiology
Brain Tissue
66%
Antimicrobial Agent
66%
Antimicrobial Activity
66%
Blood Plasma
58%
Cerebrospinal Fluid
50%
Bacterial Growth
50%
Pharmacokinetic
44%
Escherichia coli
43%
In Vitro
43%
Normal Human
38%
Erythrocyte
29%
Microdialysis
27%
Blood Brain Barrier
27%
Minimum Inhibitory Concentration
26%
positron emission tomographic scan
25%
Blood Level
25%
Bactericidal Activity
24%
Hypericum Perforatum Extract
22%
Enterococcus faecalis
22%
P-Glycoprotein
22%
Steady State
18%
Infectious Agent
17%
Platelet
14%
Mental Capacity
12%
Growth Regulation
11%
Pharmacodynamics
10%
Pseudomonas aeruginosa
10%
Staphylococcus aureus
10%
Loading Drug Dose
9%
Central Nervous System
9%
Hypericum perforatum
7%
Blood Component
7%
Host Factor
7%
High Performance Liquid Chromatography
6%
Hepatobiliary System
5%
Gall Bladder
5%
Body Fluid
5%
Bacterial Count
5%
Colony-Forming Unit
5%
Colony Forming Unit S
5%
Medicine and Dentistry
Cancer Cell
47%
Prasterone
41%
Cell Line
36%
Breast Cancer
33%
MCF-7
33%
Steroid Metabolism
33%
Sulfation
25%
Metabolite
22%
Carboplatin
22%
Cancer Model
22%
Uterine Cancer
22%
Androgen
22%
Resveratrol
22%
Cell Proliferation
22%
Endometrium Carcinoma
22%
Sulfatase
22%
Estrogen Receptor Positive Breast Cancer
22%
Ovarian Cancer
22%
Incubation
19%
Estrone Sulfate
19%
Diethylstilbestrol
16%
Cancer Growth
13%
Androstenedione
13%
Estrogen Receptor Alpha
13%
Interleukin 6
11%
Estrone
11%
Mass Spectrum
11%
Menopausal Symptom
11%
Cell Growth
11%
Supplementation
8%
Sulfate
8%
Hormone Precursor
8%
Precursor
5%
Detoxication
5%
Treatment Option
5%
Drug Resistance
5%
Estrogen Metabolism
5%
Antiestrogen
5%
Tocilizumab
5%
Cytoreductive Surgery
5%
Liquid Chromatography
5%
Digestant
5%
Androgen Metabolism
5%
Cell Culture Assays
5%
CYP1B1
5%
Estrogen Activity
5%
Estrogen Synthesis
5%
IC50
5%
Ovarian Cancer Cell Line
5%
Aerobic Metabolism
5%
